期刊
SCIENTIFIC REPORTS
卷 5, 期 -, 页码 -出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/srep11162
关键词
-
资金
- National Basic Research Program of China [2012CB517805]
- National Natural Science Foundation of China [91439120, 81170248, 31271254, 81370356, 31171095]
Salusin beta is a multifunctional bioactive peptide and is considered as a promising candidate biomarker for predicting atherosclerotic cardiovascular diseases. The present study was designed to investigate the roles and mechanisms of salusin beta in the paraventricular nucleus (PVN) in attenuating hypertension and hypothalamic inflammation and whether central salusin beta blockade has protective effects in essential hypertension. Normotensive Wistar-Kyoto (WKY) rats and spontaneously hypertensive rats (SHR) were used in this study. The rats were chronic PVN infusion either specific salusin beta blocker, antisalusin beta IgG (SIgG), or control IgG (CIgG) for 2 weeks. Hypertensive rats had significantly increased salusin beta expression compared with normotensive rats. Central blockade of salusin beta attenuated hypertension, reduced circulating norepinephrine (NE) levels, and improved cardiac hypertrophy and function in hypertensive rats. Salusin beta blockade significantly reduced proinflammatory cytokines (PICs), nuclear factor-kappa B (NF-kappa B) activity, reactive oxygen species (ROS) levels, and altered renin-angiotensin system (RAS) components in the PVN of hypertensive rats. These findings suggest that the beneficial effects of salusin beta blockade in essential hypertension are possibly due to down-regulate of inflammatory molecules and ROS in the PVN.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据